Functional nucleotides of U5 LTR determining substrate specificity of prototype foamy virus integrase

被引:0
|
作者
Kang, Seung Yi [1 ]
Ahn, Dog Gn [1 ]
Lee, Chan [2 ]
Lee, Yong Sup [3 ]
Shin, Cha-Gyun [1 ]
机构
[1] Chung Ang Univ, Dept Biotechnol, Ansung 456756, South Korea
[2] Chung Ang Univ, Dept Food Sci & Technol, Ansung 456756, South Korea
[3] Kyung Hee Univ, Coll Pharm, Kyung Hee EW Pharmaceut Res Inst, Seoul 130701, South Korea
关键词
integrase; foamy; 3'-end processing; retroviral; U5; LTR;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In order to study functional nucleotides in prototype foamy virus (PFV) DNA on specific recognition by PFV integrase (IN), we designed chimeric U5 long terminal repeat (LTR) DNA substrates by exchanging comparative sequences between human immunodeficiency virus type-1 (HIV-1) and PFV U5 LTRs, and investigated the 3'-end processing reactivity using HIV-1 and PFV INs, respectively. HIV-1 IN recognized the nucleotides present in the fifth and sixth positions at the 3'-end of the substrates more specifically than any other nucleotides in the viral DNA. However, PFV IN recognized the eighth and ninth nucleotides as distinctively as the fifth and sixth nucleotides in the reactions. In addition, none of the nucleotides present in the twelfth, sixteenth, seventeenth, eighteenth, nineteenth, and twentieth positions were not differentially recognized by HIV-1 and PFV INs, respectively. Therefore, our results suggest that the functional nucleotides that are specifically recognized by its own IN in the PFV U5 LTR are different from those in the HIV-1 U5 LTR in aspects of the positions and nucleotide sequences. Furthermore, it is proposed that the functional nucleotides related to the specific recognition by retroviral INs are present inside ten nucleotides from the 3'-end of the U5 LTR.
引用
收藏
页码:1044 / 1049
页数:6
相关论文
共 10 条
  • [1] Solution Conformations of Prototype Foamy Virus Integrase and Its Stable Synaptic Complex with U5 Viral DNA
    Gupta, Kushol
    Curtis, Joseph E.
    Krueger, Susan
    Hwang, Young
    Cherepanov, Peter
    Bushman, Frederic D.
    Van Duyne, Gregory D.
    STRUCTURE, 2012, 20 (11) : 1918 - 1928
  • [2] Functional and structural characterization of the integrase from the prototype foamy virus
    Valkov, Eugene
    Gupta, Saumya Shree
    Hare, Stephen
    Helander, Anna
    Roversi, Pietro
    McClure, Myra
    Cherepanov, Peter
    NUCLEIC ACIDS RESEARCH, 2009, 37 (01) : 243 - 255
  • [3] Inhibition of HIV-1 integrase by modified oligonucleotides derived from U5′ LTR
    Snásel, J
    Rejman, D
    Liboska, R
    Tocík, Z
    Ruml, T
    Rosenberg, I
    Pichová, I
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (04): : 980 - 986
  • [4] Functional identification of nucleotides conferring substrate specificity to retroviral integrase reactions
    Balakrishnan, M
    Jonsson, CB
    JOURNAL OF VIROLOGY, 1997, 71 (02) : 1025 - 1035
  • [5] Functional human endogenous retroviral LTR transcription start sites are located between the R and U5 regions
    Kovalskaya, E
    Buzdin, A
    Gogvadze, E
    Vinogradova, T
    Sverdlov, E
    VIROLOGY, 2006, 346 (02) : 373 - 378
  • [6] Specific and independent recognition of U3 and U5 att sites by human immunodeficiency virus type 1 integrase in vivo
    Masuda, T
    Kuroda, MJ
    Harada, S
    JOURNAL OF VIROLOGY, 1998, 72 (10) : 8396 - 8402
  • [7] Molecular Insights into the Substrate-Assisted Mechanism of Viral DNA 3′-End Processing in Intasome of Prototype Foamy Virus Integrase from Molecular Dynamic and QM/MM Studies
    Krzeminska, Agnieszka
    Swiderek, Katarzyna
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2019, 59 (06) : 2995 - 3005
  • [8] FUNCTIONAL-CHARACTERIZATION OF A U5 RIBOZYME - INTRACELLULAR SUPPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EXPRESSION
    DROPULIC, B
    LIN, NH
    MARTIN, MA
    JEANG, KT
    JOURNAL OF VIROLOGY, 1992, 66 (03) : 1432 - 1441
  • [9] Pre-existing mutations in the U5 viral DNA end of the HIV-1 LTR do not affect response to the integrase inhibitor elvitegravir: data from Study GS-US-183-0105
    Svarovskaia, E. S.
    Hluhanich, R. M.
    Goodman, D.
    Margot, N. A.
    McColl, D. J.
    Miller, M. D.
    Borroto-Esoda, K.
    ANTIVIRAL THERAPY, 2008, 13 (04) : A16 - A16
  • [10] The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3′-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors
    Tramontano, E
    Onidi, L
    Esposito, F
    Badas, R
    La Colla, P
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (09) : 1751 - 1761